Cumberland Pharmaceuticals (CPIX) Reports Q2 Loss of $0.05

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q2 EPS of ($0.05), versus $0.00 reported last year. Revenue for the quarter came in at $8.67 thousand, versus $0 reported last year.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
• Is the global equity rally broadening? UBS weighs in
• Analog Devices (ADI) Tops Q3 EPS by 11c, Beats on Revenue; Offers Q4 Guidance